logo

Latest Financial Updates

Read latest financial news update from our blog

09013027390
09013027390

Admin | Finance | 2 months ago

The Mirror Trap: AI Ethics And The Collapse Of Human Imagination
The Mirror Trap: AI Ethics And The Collapse Of Human Imagination

Synthetic reflections replace human identity in the accelerating collapse of AI ethics. ge...

Admin | Finance | 2 months ago

Banco de Chile Announces BCH Files 2024 20F Annual Report | BCH Stock News
Banco de Chile Announces BCH Files 2024 20F Annual Report | BCH Stock News

Banco de Chile (BCH, Financial) files its 2024 Annual Report (Form 20-F) with the SEC. Th...

Admin | Finance | 2 months ago

ELF DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action -- ELF
ELF DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action -- ELF

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor right...

Admin | Finance | 2 months ago

Banco de Chile Announces BCH Files 2024 20F Annual Report
Banco de Chile Announces BCH Files 2024 20F Annual Report

SANTIAGO, CHILE / ACCESS Newswire / April 27, 2025 / Banco de Chile (NYSE:BCH, Financial)...

Admin | Finance | 2 months ago

Intel: Now Or Never
Intel: Now Or Never

After a series of missteps over the years, Intel, once the market leader and a sign of inn...

Admin | Finance | 2 months ago

Dianthus Therapeutics (DNTH) Sees Rise in Short Interest Despite Stock Rebound | DNTH Stock News
Dianthus Therapeutics (DNTH) Sees Rise in Short Interest Despite Stock Rebound | DNTH Stock News

Short interest in Dianthus Therapeutics (DNTH, Financial) has increased notably, reaching...

Admin | Finance | 2 months ago

OLYMPUS Long-Term Follow-Up Study Reports Nearly Four-Year Duration of Response in Subset of Patients with Low-Grade Upper Tract Urothelial Cancer Who Achieved a Complete Response to Initial JELMYTO T
OLYMPUS Long-Term Follow-Up Study Reports Nearly Four-Year Duration of Response in Subset of Patients with Low-Grade Upper Tract Urothelial Cancer Who Achieved a Complete Response to Initial JELMYTO T

UroGen Pharma Ltd. (URGN, Financial) reports nearly four-year duration of response for cer...

Admin | Finance | 2 months ago

Join Our Newsletter

join our newsletter to receive update from us

whatsapp logo

Equity Cooperative Investment Company
Typically replies within a day

Hi!


Welcome to Equity Cooperative Investment!

How may I help you today?

Start Chat